mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.095 |
0.09 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |